It’s a familiar refrain in oral solid dosage: patients overwhelmingly prefer oral meds to needles. But even the world’s favorite dosage form has had its share of growing pains.
Early oral medicines were notoriously bitter and often degraded before they could do their jobs. In 1834, pharmacist Joseph Dublanc and his student Francois Mothes patented the gelatin capsule, masking unpleasant tastes and protecting sensitive drugs. These first “gelatinous capsules” were filled by hand with liquid medicines and sealed with a drop of gelatin — an innovation that improved both stability and patient experience.
Still, manufacturing lagged behind the idea. That finally changed in 1931, when Robert Pauli Scherer, working out of his parents’ basement in Detroit, invented the rotary die press. For the first time, gelatin capsules could be filled and sealed at scale. The resulting liquid-filled capsules brought faster absorption and improved bioavailability to the masses.
But as time went on, the nature of APIs began to change. Many were poorly soluble, highly potent, and necessitated low-dose administration. While liquid-filled capsules could help address dose uniformity challenges, solubility issues and reduce operator exposure, soft gelatin capsules had their limits. Certain fill materials proved incompatible. Leakage risks persisted. Production required specialized, expensive gelatin preparation equipment and significant facility space. In short, the flexibility floodgates had yet to fully open.
Hard-shell capsules had long delivered powders, but in the early 1980s, the introduction of high-speed band sealing machines enabled manufacturers to fill them with liquids. Liquid-filled hard capsules (LFHCs) offered a compelling alternative to soft gelatin. Pre-made shells eliminated the need for in-house shell production, allowing liquid filling with readily available equipment. LFHCs expanded formulation options, improved stability, and met evolving consumer preferences.
And liquid-filled innovation has not slowed. Today’s filling lines incorporate servo-driven pumps, precise temperature control, and integrated inspection systems capable of real-time monitoring. New machine designs aim to handle a wider range of viscosities and fill volumes while maintaining high accuracy and throughput.
Meanwhile, polymer science is reshaping shell materials. Cellulose-based and other alternatives offer tailored disintegration, improved barrier properties, and greater supply-chain flexibility. These advances enable more more sophisticated control of release profiles and stability for liquid fills.
From hand-filled gelatin shells to precision-engineered liquid delivery systems, the capsule has never stood still. And if history tells us anything, it’s this: in drug delivery, progress doesn’t come in bursts. It flows — steady, adaptable and always moving forward.